Agil® 100 EC Letònia - letó - Adama

agil® 100 ec

adama - emulsijas koncentrāts - propakvizafops - herbicīdi

Elegant® 2FD Letònia - letó - Adama

elegant® 2fd

adama - suspo-emulsija - 2.4d + florasulams - herbicīdi

Camcevi Unió Europea - letó - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - prostatas audzēji - endokrīnā terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Cevenfacta Unió Europea - letó - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorāģija - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.